Did You Know?

Editor’s Picks

Latest News

PointClickCare Introduces AI-Informed SNF Discharge Planning Intelligence, Giving Health Plans, ACOs, and Hospitals a Unified View of Discharge Plan Completeness

New capabilities bring structured assessments and AI-curated discharge insights together to help care managers coordinate safer, faster transitions from skilled...

As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment – with Superior Oral Administration and Escape Resistance Features Over Antibodies

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA...

error: Content is protected !!